Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 2021

View Archived Issues

HDAC6 linked to higher risk of relapse in HER2-positive breast cancer treated with trastuzumab

Shanghai Institutes for Biological Sciences presents islet-like cell clusters

iNtRON Biotechnology patents Myoviridae bacteriophage compositions

New BRD4 BD2 inhibitors discovered at Betta Pharmaceuticals

Medshine Discovery identifies new CCR5/CCR1 antagonists

Beijing Findcure Biosciences divulges tyrosine-protein kinase receptor UFO inhibitors

NCC-1566 demonstrates synergistic effect with levetiracetam in pharmacoresistant 6 Hz model

Stomach organoid created from multiple stem cell types

Mdm2 gene amplification is associated with poor outcome of patients with luminal breast cancer

lncRNA XIST could be used to select triple-negative breast cancer patients for ERbeta therapy

MDX-124 shows efficacy in preclinical models of TNBC

BetterLife's TD-0148A reverses depressive-like behavior in chronically stressed mice

Totus receives financing to advance TOS-358 drug program for cancer

CRISPR-Cas9 gRNA system eliminates diverse proviral HIV-1 strains

NextVivo launches to develop immune organoid technology platform

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...